| Q49774282 | Curative versus palliative treatments for colorectal cancer with peritoneal carcinomatosis: a systematic review and meta-analysis |
| Q33703086 | Impact of experimental and demographic variables in serum peptide profiling based on magnetic bead and MALDI-TOF mass spectrometry |
| Q37320785 | Infliximab enhances the therapeutic effects of 5-fluorouracil resulting in tumor regression in colon cancer |
| Q91074053 | Inhibition of lncRNA NEAT1 suppresses the inflammatory response in IBD by modulating the intestinal epithelial barrier and by exosome-mediated polarization of macrophages |
| Q36562258 | The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB. |
| Q37564425 | The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer. |
| Q87812030 | [Association between serum levels of S100A8/S100A9 and clinical features of colorectal cancer patients] |
| Q36545987 | miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1. |